Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway
Lehe Yang, Feng Zhou, Yan Zhuang, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 3, pp. 645-657
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
Maliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112963-112963
Open Access | Times Cited: 81
Steroidal Saponins: Naturally Occurring Compounds as Inhibitors of the Hallmarks of Cancer
Salwa Bouabdallah, Amna Al-Maktoum, Amr Amin
Cancers (2023) Vol. 15, Iss. 15, pp. 3900-3900
Open Access | Times Cited: 49
Bufalin for an innovative therapeutic approach against cancer
Laura Soumoy, Ghanem E. Ghanem, Sven Saussez, et al.
Pharmacological Research (2022) Vol. 184, pp. 106442-106442
Closed Access | Times Cited: 56
Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Yalda Saghari, et al.
International Journal of Biological Macromolecules (2022) Vol. 206, pp. 435-452
Closed Access | Times Cited: 44
Toad venom bufadienolides and bufotoxins: An updated review
Akmal M. Asrorov, Muzaffar Kayumov, Nurkhodja Mukhamedov, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 815-838
Closed Access | Times Cited: 24
Xie-Bai-San increases NSCLC cells sensitivity to gefitinib by inhibiting Beclin-1 mediated autophagosome formation
Changju Ma, Xin Zhang, Xiaomin Mo, et al.
Phytomedicine (2024) Vol. 125, pp. 155351-155351
Open Access | Times Cited: 8
Cinobufagin suppresses colorectal cancer growth via STAT3 pathway inhibition.
Ying Bai, Xuye Wang, Mengsi Cai, et al.
American Journal of Cancer Research (2021) Vol. 11, Iss. 1, pp. 200-214
Closed Access | Times Cited: 42
Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer
Zhucheng Zhao, Yanmao Wang, Yuyan Gong, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 30
Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell Lung Cancer
Tizhi Wu, Bin Yu, Yifan Xu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15340-15361
Closed Access | Times Cited: 17
GPR37 promotes cancer growth by binding to CDK6 and represents a new theranostic target in lung adenocarcinoma
Xiaona Xie, Xueding Cai, Feng Zhou, et al.
Pharmacological Research (2022) Vol. 183, pp. 106389-106389
Open Access | Times Cited: 25
Bufalin-Mediated Regulation of Cell Signaling Pathways in Different Cancers: Spotlight on JAK/STAT, Wnt/β-Catenin, mTOR, TRAIL/TRAIL-R, and Non-Coding RNAs
Ammad Ahmad Farooqi, Venera Rakhmetova, Gulnara Kapanova, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2231-2231
Open Access | Times Cited: 14
Gamabufotalin inhibits colitis-associated colorectal cancer by suppressing transcription factor STAT3
Nian Jiang, Sanhua Li, Lingjie Meng, et al.
European Journal of Pharmacology (2024) Vol. 966, pp. 176372-176372
Closed Access | Times Cited: 5
Self-assembly of multi-arm star PEG containing TXA9 into nanoparticle for the efficient chemotherapy of NSCLC
Qilong Wang, Zhe Liu, Jiale Yao, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Rational Design of a Potent, Selective, and Metabolically Stable CDK9 Inhibitor to Counteract Osimertinib Resistance through Mcl-1 Suppression and Enhanced BRD4 Co-Targeting
Tizhi Wu, Jiali Huang, Xiankang Zhang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
α-Mangostin Exhibits Antitumor Activity Against NCI-H1975 Cells via the EGFR/STAT3 Pathway: An Experimental and Molecular Simulation Study
Jing Wang, Jing Xian, Ruohan Zhang, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1294-1294
Open Access
A patent review of selective CDK9 inhibitors in treating cancer
Tizhi Wu, Xiaowei Wu, Yifan Xu, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 4, pp. 309-322
Closed Access | Times Cited: 9
Repurposing diacerein to suppress colorectal cancer growth by inhibiting the DCLK1/STAT3 signaling pathway
Qiaobei YE, Yu Zhu, Meng Shi, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 4, pp. 318-328
Closed Access | Times Cited: 3
Bufalin-Loaded Multifunctional Photothermal Nanoparticles Inhibit the Anaerobic Glycolysis by Targeting SRC-3/HIF-1α Pathway for Improved Mild Photothermal Therapy in CRC
Jing Shang, Qi Xia, Yuji Sun, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7831-7850
Open Access | Times Cited: 3
Stimuli-responsive polyprodrug for cancer therapy
Chia‐Chin Lin, Yixia Liang, Mingyan Guo, et al.
Materials Today Advances (2022) Vol. 15, pp. 100266-100266
Open Access | Times Cited: 16
Telocinobufagin Has Antitumor Effects in Non-Small-Cell Lung Cancer by Inhibiting STAT3 Signaling
Yili Shen, Haijian Cai, Shen-jie Ma, et al.
Journal of Natural Products (2022) Vol. 85, Iss. 4, pp. 765-775
Closed Access | Times Cited: 14
Nanoparticle-Mediated Delivery of STAT3 Inhibitors in the Treatment of Lung Cancer
Qiyi Feng, Kai Xiao
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2787-2787
Open Access | Times Cited: 14
Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway
Yufeng Qi, Haodong Wu, Tianru Zhu, et al.
Aging (2023) Vol. 15, Iss. 16, pp. 8258-8274
Open Access | Times Cited: 8
Targeting cyclin-dependent kinase 9 in cancer therapy
Yili Shen, Yanmao Wang, Yaxin Zhang, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 7, pp. 1633-1645
Open Access | Times Cited: 19
Nanocarrier mediated co-delivery of phytochemicals and chemo-drugs: an emerging strategy to combat lung cancer in a systemic way
Priyanka Upadhyay, Avijit Ghosh, Vijaya Sarangthem, et al.
Phytochemistry Reviews (2023) Vol. 23, Iss. 2, pp. 485-527
Closed Access | Times Cited: 7
Transcriptional inhibition by CDK7/9 inhibitor SNS-032 suppresses tumor growth and metastasis in esophageal squamous cell carcinoma
Huishan Zeng, Huiru Yang, Yifan Song, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top